Expanded Access Programs

Expanded Access Programs (EAPs) allow patients with serious or life-threatening conditions to receive investigational drugs outside of clinical trials when no other approved treatments are available. These programs provide a regulated way for patients to access promising therapies earlier in their development process, often under the supervision of their healthcare providers. EAPs are carefully monitored to ensure safety and proper use, offering hope to patients facing unmet medical needs while balancing potential risks and benefits.